Azacytidine-treated MDS patients at risk for invasive fungal infectionMay 3, 2021Myelodysplastic Syndrome
Azacitidine may allow bridging to salvage allo-HSCT after hematologic relapse May 3, 2021Myelodysplastic Syndrome
Hematology NewsVEXAS: A novel rheumatologic, hematologic syndrome that’s making wavesApril 7, 2021Myelodysplastic SyndromeAnemiaLeukemia, Myelodysplasia, TransplantationRare Diseases
High-risk MDS: Stanozolol improves PFS after effective induction therapy with decitabineApril 2, 2021Myelodysplastic Syndrome
Comorbidities and prior malignancy negatively impact survival in MDSApril 2, 2021Myelodysplastic Syndrome
TP53-mutated MDS: EAp53 score identifies subsets with favorable prognosisApril 2, 2021Myelodysplastic Syndrome
MDS: SNP-A and UPD provide a new perspective for risk stratificationApril 2, 2021Myelodysplastic Syndrome
High-risk MDS: D-IA regimen shows promise in chemotherapy ineligible patients April 2, 2021Myelodysplastic Syndrome
Systemic PNH testing could allow better prediction and clinical follow-up in MDSApril 2, 2021Myelodysplastic Syndrome
